Tumorzentrum der Universität Erlangen-Nürnberg

Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts (2024) Bahlinger V, Branz A, Strissel P, Strick R, Lange F, Geppert CI, Klümper N, et al. Journal article Current landscape of hospital information systems in gynecology and obstetrics in Germany: a survey of the commission Digital Medicine of the German Society for Gynecology and Obstetrics (2023) Pfob A, Griewing S, Seitz K, Hillen C, Becker S, Bayer C, Wagner U, et al. Journal article The modified Polsby–Popper score, a novel quantitative histomorphological biomarker and its potential to predict lymph node positivity and cancer-specific survival in oral tongue squamous cell carcinoma (2023) Csűry TD, Csűry AZ, Balk M, Kist A, Rupp R, Müller SK, Sievert M, et al. Journal article RANK and RANKL Expression in Tumors of Patients with Early Breast Cancer (2023) Behrens A, Wurmthaler L, Heindl F, Gaß P, Häberle L, Volz B, Hack C, et al. Journal article Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer (2023) Slamon DJ, Fasching P, Hurvitz S, Chia S, Crown J, Martín M, Barrios CH, et al. Journal article Detailed in vitro analyses of the impact of multimodal cancer therapy with hyperthermia and radiotherapy on the immune phenotype of human glioblastoma cells (2022) Stoll E, Hader M, Rückert M, Weissmann T, Lettmaier S, Putz F, Hecht M, et al. Journal article Improved Bladder Tumor RNA Isolation from Archived Tissues Using Methylene Blue for Normalization, Multiplex RNA Hybridization, Sequencing and Subtyping (2022) Köhler S, Brandl L, Strissel P, Glossner L, Ekici AB, Angeloni M, Ferrazzi F, et al. Journal article, Original article Treatment-relevant biomarkers in gynecologic oncology (2022) Ditsch N, Fasching P Journal article Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World Setting (2022) Erber R, Angeloni M, Stöhr R, Lux MP, Ulbrich-Gebauer D, Pelz E, Bankfalvi A, et al. Journal article Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study (2022) Welland S, Leyh C, Finkelmeier F, Jefremow A, Shmanko K, Gonzalez-Carmona MA, Kandulski A, et al. Journal article